News
Zacks Investment Research on MSN5d
AZN Gets EU Nod for Expanded Use of Two Separate Cancer DrugsAstraZeneca AZN and partner Daiichi Sankyo announced that the European Commission has approved the expanded use of Enhertu ...
The trial will include patients with locally advanced or metastatic HER2-positive, PD-L1-positive gastric or gastroesophageal junction cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback